Second Department of Cardiology, Athens University Medical School, Attikon Hospital, Athens, Greece.
Second Department of Cardiology, Athens University Medical School, Attikon Hospital, Athens, Greece.
Atherosclerosis. 2014 May;234(1):34-41. doi: 10.1016/j.atherosclerosis.2014.02.004. Epub 2014 Feb 18.
Lipoprotein-associated Phospholipase A2 (Lp-PLA2), has a powerful inflammatory and atherogenic action in the vascular wall and is an independent marker of poor prognosis in coronary artery disease (CAD). We investigate the association of Lp-PLA2 with markers of vascular dysfunction and atherosclerosis with proven prognostic value in CAD.
In 111 patients with angiographically documented chronic CAD, we measured 1) carotid intima-media thickness (CIMT), 2) reactive hyperemia using fingertip peripheral arterial tonometry (RH-PAT), 3) coronary flow reserve (CFR), by Doppler echocardiography 4) pulse wave velocity (PWV) and 5) blood levels of Lp-PLA2.
Patients with Lp-PLA2 concentration >234.5 ng/ml (50th percentile) had higher CIMT (1.44 ± 0.07 vs. 1.06 ± 0.06 mm), PWV (11.0 ± 2.36 vs. 9.7 ± 2.38 m/s) and lower RH-PAT(1.24 ± 0.25 vs. 1.51 ± 0.53) and CFR (2.39 ± 0.75 vs. 2.9 ± 0.86) compared to those with lower Lp-PLA (p < 0.05 for all comparisons). Lp-PLA2 was positively associated with CIMT (regression coefficient b: 0.30 per unit of Lp-PLA2, p = 0.02), PWV (b:0.201, p = 0.04) and inversely with RHI-PAT (b: -0.371, p < 0.001) and CFR (b:-0.32, p = 0.002). In multivariate analysis, Lp-PLA2 was an independent determinant of RHI-PAT, CFR, CIMT and PWV in a model including age, sex, smoking, diabetes, dyslipidemia and hypertension (p < 0.05 for all vascular markers). Lp-PLA2, RHI-PAT and CFR were independent predictors of cardiac events during a 3-year follow-up.
Elevated Lp-PLA2 concentration is related with endothelial dysfunction, carotid atherosclerosis, impaired coronary flow reserve and increased arterial stiffness and adverse outcome in CAD patients. These findings suggest that the prognostic role of Lp-PLA2 in chronic CAD may be explained by a generalized detrimental effect of this lipase on endothelial function and arterial wall properties.
脂蛋白相关磷脂酶 A2(Lp-PLA2)在血管壁中具有强大的炎症和动脉粥样硬化作用,是冠心病(CAD)预后不良的独立标志物。我们研究了 Lp-PLA2 与血管功能障碍和动脉粥样硬化标志物的相关性,这些标志物在 CAD 中具有明确的预后价值。
在 111 例经血管造影证实的慢性 CAD 患者中,我们测量了 1)颈动脉内膜中层厚度(CIMT),2)指尖外周动脉张力测定(RH-PAT)的反应性充血,3)多普勒超声心动图的冠状动脉血流储备(CFR),4)脉搏波速度(PWV)和 5)Lp-PLA2 的血液水平。
Lp-PLA2 浓度>234.5ng/ml(第 50 百分位数)的患者 CIMT(1.44±0.07 vs.1.06±0.06mm)、PWV(11.0±2.36 vs.9.7±2.38m/s)和 RH-PAT(1.24±0.25 vs.1.51±0.53)和 CFR(2.39±0.75 vs.2.9±0.86)均较高,而 Lp-PLA 较低的患者(所有比较均为 p<0.05)。Lp-PLA2 与 CIMT(回归系数 b:每单位 Lp-PLA2 增加 0.30,p=0.02)、PWV(b:0.201,p=0.04)呈正相关,与 RH-PAT(b:-0.371,p<0.001)和 CFR(b:-0.32,p=0.002)呈负相关。在包括年龄、性别、吸烟、糖尿病、血脂异常和高血压的多变量分析中,Lp-PLA2 是 RH-PAT、CFR、CIMT 和 PWV 的独立决定因素(所有血管标志物的 p<0.05)。Lp-PLA2、RH-PAT 和 CFR 是 CAD 患者 3 年随访期间心脏事件的独立预测因子。
升高的 Lp-PLA2 浓度与内皮功能障碍、颈动脉粥样硬化、冠状动脉血流储备受损以及动脉僵硬和不良预后有关。这些发现表明,Lp-PLA2 在慢性 CAD 中的预后作用可能是由于这种脂肪酶对内皮功能和动脉壁特性的普遍不利影响。